James Biehl - May 11, 2023 Form 4 Insider Report for Charge Enterprises, Inc. (CRGE)

Signature
/s/ JAMIE YUNG, Attorney-in-Fact
Stock symbol
CRGE
Transactions as of
May 11, 2023
Transactions value $
$0
Form type
4
Date filed
5/15/2023, 08:01 PM
Previous filing
Nov 2, 2022
Next filing
May 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRGE Restricted Stock Unit Disposed to Issuer $0 -100K -100% $0.00* 0 May 11, 2023 Common Stock 100K $0.00 Direct F1, F2
transaction CRGE Options, right to buy Award $0 +200K $0.00 200K May 11, 2023 Common stock 200K $0.97 Direct F3
transaction CRGE Options, right to buy Award $0 +500K $0.00 500K May 11, 2023 Common stock 500K $0.97 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represented the right to receive one share of common stock upon vesting.
F2 On October 31, 2022, the Reporting Person was granted 100,000 RSUs. The RSUs were to vest pursuant to a three-year vesting schedule, whereby one-third of the total number of shares were to vest each year on the anniversary of the grant date, subject to continued employment with the Issuer. On May 11, 2023, the RSUs were cancelled.
F3 On May 11, 2023, the Reporting Person was granted an option to purchase 200,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan. Such option will vest pursuant to a three-year vesting schedule, whereby one-third of the total number of shares will vest each year on October 31, commencing October 31, 2023. The option is exercisable for a term of ten years.
F4 On May 11, 2023, the Reporting Person was granted an option to purchase 500,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan. The option will vest quarterly over four years from the date of the grant. The option is exercisable for a term of ten years.